Organisation: Position: Deadline Date: Location:


April 25th, 2018 The worldwide resurgence of malaria, which kills half a million people a year, has sparked philanthropists, business leaders and ministers from donor and malaria-affected countries to pledge $4.1bn to drive research and innovation and improve access...

Weekly Roundup


Medical marijuana could increase drug use risk

A study finds that people who use medical marijuana have higher rates of medical and non-medical prescription drug use – including pain relievers. Rather than being at lower risk, people who use medical marijuana may be at higher risk for... April 25th, 2018


No evidence that anaesthesia before 3-years impacts on child's IQ

A Mayo Clinic study finds no evidence that children given anaesthesia before their third birthdays have lower IQs than those who did not have it. A more complex picture emerges among people who had anaesthesia several times as small children:... April 25th, 2018


Traditional methods for testing BP no longer adequate — study

Traditional methods of testing for high-blood pressure are no longer adequate and risk missing vital health signs, which can lead to premature death, a study co-led by University College London (UCL) has found. The research, the largest ever cohort... April 25th, 2018


Artificial pancreas better controls blood sugar levels

Use of an artificial pancreas is associated with better control of blood sugar levels for people with type 1 diabetes compared with standard treatment, finds a review of the available evidence. The findings show that artificial pancreas treatment... April 25th, 2018


Greater risk of toxic shock syndrome from menstrual cups

Toxic shock syndrome (TSS) has long-been associated with tampon use, but a study claims that menstrual cups could pose an even greater risk. The Independent reports that favoured for their economical and eco-friendly properties, menstrual cups have... April 25th, 2018



Puzzle over whether HIV accelerates cancer progression

Although people living with HIV may be diagnosed with cancer at an earlier stage because they get more consistent care than the general population, it is also possible that a higher likelihood of late cancer diagnosis among people with HIV is an... April 25th, 2018

TAF only superior to TDF when used with a boosting agent

The benefits of tenofovir alafenamide (TAF) over tenofovir disoproxil fumarate (TDF) may have been overstated, according to the results of a meta-analysis. It was only when used in an antiretroviral therapy regimen containing a boosting agent that... April 25th, 2018



Thank you for subscribing to MedicalBrief

MedicalBrief is Africa’s premier medical news and research weekly newsletter. MedicalBrief is published every Thursday and delivered free of charge by email to over 33 000 health professionals.

Please consider completing the form below. The information you supply is optional and will only be used to compile a demographic profile of our subscribers. Your personal details will never be shared with a third party.

Thank you for taking the time to complete the form.